The Medical Advisor

Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated:   September  2026 If you have been diagnosed with cancer, or have a loved one that is suffering from cancer, chances are you have heard about the Joe Tippens Cancer Protocol. The Fenbendazole Cancer Protocol has been gaining rapid interest over the past years following some fenbendazole advanced cancer success stories  and a recent peer-reviewed publication, " Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients : Results from a Prospective Observational Cohort ( Anticancer Research 2026 )" We have seen tremendous demand for some sort of guide on how to use fenbendazole for cancer as there is also tremendous confusion both from the healthcare and non-healthcare communities. Joe Tippens founded the protocol (1) after he was told a s...

Medically Reviewed by: OneDayMD Editorial Team | Last Updated: July 2026 Abstract Background: Repurposed antiparasitic agents, including ivermectin and benzimidazoles (fenbendazole and mebendazole), have gained attention for their potential anticancer properties, particularly in colorectal cancer. Preclinical studies suggest these agents may exert antitumor effects through mechanisms such as inhibition of cell proliferation and disruption of key oncogenic pathways, including Wnt/β-catenin signaling. Objective: To summarize and evaluate a compilation of case reports describing the use of ivermectin and benzimidazole-based regimens in patients with colorectal cancer, with a focus on advanced-stage disease. Methods: This review analyzes a curated series of 80+ case reports involving patients with colorectal or related gastrointestinal cancers treated with ivermectin in combination with fenbendazole or mebendazole, often alongside standard therapies such as chemotherapy. Reported out...